webleads-tracker

Cloudy Outlook as Sun Rises on Open Payments

The US database disclosing transfers of value from pharma and medical technology companies to doctors went live at the end of September with details of 4.4 million transactions. But there are complaints it has not delivered transparency.
Robert Wah, President of the American Medical Association (AMA) said he is “very concerned” about the accuracy of the data. “Only 26,000 physicians out of the nearly 550,000 physicians affected by the Sunshine Act were able to register to review their data and seek correction of any inaccuracies,” Wah said.
Publishing inaccurate data leads to misinterpretations, harms reputations and undermines the trust that patients have in their physicians. It can also discourage research and care, the AMA said.
To read the article by the EFPIA

Check Also

Pharma Compliance Info The Patient Advocacy Groups that Accept the Most Big Pharma Money US Sunshine Act

The Patient Advocacy Groups that Accept the Most Big Pharma Money

Eight out of ten patient advocacy groups accept money from drug and medical device companies. …

X